*ST Jiyou announced that the company plans to acquire more than 50% of Jiangsu Huiju Pharmaceutical's shares in cash and obtain control, which is expected to constitute a major asset restructuring and related transaction. On June 18, 2026, the company and shareholders of the target company signed the “Stock Acquisition Intent Agreement”. As of the date of disclosure of the announcement, the company is promoting due diligence, audit, evaluation, etc., and communicating and negotiating with relevant parties. The parties involved in the transaction have not yet signed a formal agreement, and there is uncertainty about whether it can be implemented and the progress.
Zhitongcaijing · 2d ago
Share
Listen to the news
*ST Jiyou announced that the company plans to acquire more than 50% of Jiangsu Huiju Pharmaceutical's shares in cash and obtain control, which is expected to constitute a major asset restructuring and related transaction. On June 18, 2026, the company and shareholders of the target company signed the “Stock Acquisition Intent Agreement”. As of the date of disclosure of the announcement, the company is promoting due diligence, audit, evaluation, etc., and communicating and negotiating with relevant parties. The parties involved in the transaction have not yet signed a formal agreement, and there is uncertainty about whether it can be implemented and the progress.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending